Windtree Therapeutics, Inc.
- UEI
- MLFQZEK9E745
- CAGE
- 5EKW9
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| "K4L surfactant aerosol to reduce influenza lung injury" | National Institute of Allergy and Infectious Diseases | $225,000 | |
| KL4 surfactant to mitigate radiation-induced lung injury | National Institutes of Health | $600,000 | |
| KL4 surfactant to mitigate radiation-induced lung injury | National Institute of Allergy and Infectious Diseases | $2,977,799 | |
| Development & utilization of a novel aerosol-generating technology to deliver LUC | National Heart Lung and Blood Institute | $5,105,805 |
Quick answers
What is Windtree Therapeutics, Inc.'s UEI?
Windtree Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is MLFQZEK9E745.
What is Windtree Therapeutics, Inc.'s CAGE code?
Windtree Therapeutics, Inc.'s CAGE code is 5EKW9.
What is Windtree Therapeutics, Inc.'s primary NAICS code?
Windtree Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Windtree Therapeutics, Inc. registered in SAM.gov?
Windtree Therapeutics, Inc.'s SAM.gov registration expired on April 16, 2024.
What is Windtree Therapeutics, Inc.'s most recent federal award?
Windtree Therapeutics, Inc.'s most recent federal contract award is "K4L surfactant aerosol to reduce influenza lung injury" (HHSN272201500027C), from National Institute of Allergy and Infectious Diseases, on August 25, 2015.
On GovTribe
See Windtree Therapeutics, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors